Latest Australian Manufacturing News

AdAlta has launched its East-to-West cellular immunotherapy strategy through a co-development deal for CAR-T therapy BZDS1901, showing promising complete tumour clearance in mesothelioma patients and transferring manufacturing to Australia to boost scalability.

AdAlta has secured Australian manufacturing for its lead CAR-T therapy BZDS1901, which has shown rare complete tumour clearance in advanced mesothelioma patients. This move is a key step toward local clinical trials and boosts the therapy’s global commercial appeal.

Biome Australia’s Activated Probiotics brand surpasses one million boxes sold in Australia, approaches top pharmacy ranking, and launches nationally in Canada, setting the stage for FY26 profitability.

Matrix Composites & Engineering has received a non-binding, indicative proposal from Advanced Innergy Holdings to acquire all shares at $0.40 each. The offer is conditional and under review by the Matrix board.

ABx Group’s ALCORE subsidiary has reached a key environmental milestone for its hydrogen fluoride pilot plant in Tasmania, progressing construction and expanding its engineering team ahead of commissioning in late 2026.

Hazer Group has inked a non-binding graphite offtake agreement with Green Steel of WA, marking a significant step in supplying low-emission steel production with up to 85,000 tonnes over 10 years.

Electro Optic Systems has secured two major counter-drone contracts worth US$45 million, highlighting rising defence demand amid Middle East conflicts. The largest order involves the Slinger Remote Weapon System for a Middle Eastern customer, with deliveries planned for 2026.

Bioxyne Limited has reported a remarkable half-year performance, with revenues soaring 149% to $31.3 million and net profit more than doubling to $7.3 million, driven by strong demand for medicinal cannabis, MDMA, and psilocybin products and expanding international operations.

PWR Holdings Limited has reported a robust half-year performance with revenues climbing 27.8% and net profit rising 38.6%, underpinned by strategic expansion in motorsports and aerospace sectors. The company also announced a higher fully franked interim dividend of 3 cents per share.

Elixinol Wellness reported a 9.5% revenue increase in Q4 FY25 alongside a 30% reduction in operating costs, setting a clear path to profitability under fresh executive leadership.

Beach Energy’s FY26 half-year results reveal steady sales volumes and a robust ramp-up at the Waitsia Gas Plant, supported by strong LNG cargo revenues and disciplined cost management.

Bioxyne Limited has delivered a record-breaking second quarter in FY2026, posting $17.2 million in revenue and expanding its footprint into key international markets. The company’s growth is underpinned by new contracts, innovative psychedelics products, and strategic government funding.